Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MRTX - Mirati Therapeutics Inc. (MRTX) CEO David Meek on Q4 2021 Results - Earnings Call Transcript

MRTX - Mirati Therapeutics Inc. (MRTX) CEO David Meek on Q4 2021 Results - Earnings Call Transcript

Mirati Therapeutics Inc.
Mirati Therapeutics, Inc. (MRTX) Q4 2021 Earnings Conference Call February 28, 2022 04:30 PM ET Company Participants Ryan Asay - Vice President of Corporate Affairs David Meek - Chief Executive Officer James Christensen - Chief Scientific Officer Ben Hickey - Chief Commercial Officer Vickie Reed - Chief Accounting Officer Conference Call Participants Tyler Van Biren - Cowen & Company Gavin Scott - JPMorgan Chase & Co. Andrea Tan - Goldman Sachs Group Inc. Evan Seigerman - BMO Capital Markets Michael Schmidt - Guggenheim Securities, LLC Benjamin Burnett - Stifel, Nicolaus & Company, Inc Kevin Strang - Jefferies LLC Michael Ulz - Morgan Stanley Carly Kenselaar - Citigroup Inc. Presentation Operator Good afternoon, and welcome to the Mirati Therapeutics Fourth Quarter 2021 Earnings Call. My name is Sarah, and I will be the operator for today's call. All lines have been placed on mute to prevent any background noise. After the

For further details see:

Mirati Therapeutics, Inc. (MRTX) CEO David Meek on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Mirati Therapeutics Inc.
Stock Symbol: MRTX
Market: NASDAQ
Website: mirati.com
Menu
MRTX MRTX Quote MRTX Short MRTX News MRTX Articles MRTX Message Board
Get MRTX Alerts

News, Short Squeeze, Breakout and More Instantly...